Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Ischemix Inc.
DescriptionSmall molecule that modulates the protein kinase B (AKT; AKT1; PKB; PKBA) pathway
Molecular Target Protein kinase B (AKT) (AKT1) (PKB) (PKBA)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationIschemia / reperfusion injury
Indication DetailsPrevent contrast-induced acute kidney injury (AKI); Prevent peri-operative ischemia/reperfusion injury in patients undergoing percutaneous coronary intervention (PCI)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today